end stage renal disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria included patients being on low-flux HD thrice a week for 6 months, with well functioning native AV fistulas for blood access , haemoglobin level ranging between 10 and 13 g/dL in the previous 3 months, stable with a minimum dialysis single-pool Kt/V for urea >=1.2.
Exclusion criteria
Exclusion criteria: Exclusion criteria included any acute illness such as infection or cardiovascular event (i.e., acute myocardial infarction) or cerebrovascular (i.e., ischemic stroke) event within the past month, severe hypertension (systolic blood pressure >180 or diastolic blood pressure >110 mmHg), current estrogen / hormone replacement therapy or intravenous ferrum or oral antiplatelet durgs (such as aspirin, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| flow-mediated dilatation (FMD%);soluble endoehelial protein C receptor;soluble thrombomodulin;interleukin-6;high sensitive C-reactive protein; | — |
Countries
China